WNK2 and metabolic dysfunction-associated steatotic liver disease: Specifically, IR and dyslipidemia trigged by NAFLD are also closely associated with endothelial dysfunction and vasoconstriction by decreasing endothelial nitric oxide production and activating the mitogen-activated protein kinase pathway (39).